CRP and melanoma: Patients who experienced no irAE were at the highest risk for melanoma relapse, while, within patients diagnosed with an irAE, those with an elevated CRP (>2xULN) were at higher risk for relapse compared to those diagnosed with an irAE and CRP < 2xULN.